Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age

Journal of Alzheimer's Disease

Volumn 26, Issue SUPPL. 3, 2011, Pages 49-60

  Fennema Notestine, Christine ^a,b   Panizzon, Matthew S ^a   Thompson, Wesley R ^a   Chen, Chi Hua ^a   Eyler, Lisa T ^a,c   Fischl, Bruce ^d,e,f   Franz, Carol E ^a   Grant, Michael D ^g   Jak, Amy J ^a,c   Jernigan, Terry L ^a,b,h,i   Lyons, Michael J ^g   Neale, Michael C ^j   Seidman, Larry J ^g   Tsuang, Ming T ^a,e,l   Xian, Hong ^l   Dale, Anders M ^c,m   Kremen, William S ^a,c,k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g BOSTON UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ University of California   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

aging; apolipoprotein E2; apolipoprotein E3; apolipoprotein E4; apolipoproteins E; brain; cerebral cortex; frontal lobe; genetic association studies; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; ENDOPHENOTYPE; FRONTAL CORTEX; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; TWINS; VIET NAM;

EID: 80055037882     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-0002     Document Type: Article

References (74)

1. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimers disease. Neurology 43, 1467-1472. (Pubitemid 23230526)
2. Bookheimer S, Burggren A (2009) APOE-4 genotype and neurophysiological vulnerability to Alzheimers and cognitive aging. Annu Rev Clin Psychol 5, 343-362.
3. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung WY, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NL, Heyman A, Clark CM, Roses AD (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48, 1034-1050. (Pubitemid 21903065)
4. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90, 1977-1981. (Pubitemid 23069980)
5. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41, 1068-1086.
6. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
7. Schipper H.M. Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment. Neurobiol Aging. (In Press)
8. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7, 180-184. (Pubitemid 24174658)
9. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D (1999) Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 30, 1548-1553. (Pubitemid 29379601)
10. Finch CE, Sapolsky RM (1999) The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 20, 407-428.
11. Bleumink GS, van Duijn CM, Kingma JH,Witteman JC, Hofman A, Stricker BH (2004) Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction. Am Heart J 147, 685-689. (Pubitemid 38900460)
12. Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S (2006) The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis. J Neurol Sci 245, 35-39. (Pubitemid 43775934)
13. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, SmallGW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
14. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van DuijnCM(1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.Ameta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356.
15. Martins CA, Oulhaj A, de Jager CA, Williams JH (2005) APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 65, 1888-1893. (Pubitemid 43970105)
16. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD (1997) Apolipoprotein E-epsilon 2 and Alzheimers disease: genotype influences pathologic phenotype. Neurology 48, 515-519. (Pubitemid 27087630)
17. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62, 1977-1983. (Pubitemid 38738207)
18. Oyama F, Shimada H, Oyama R, Ihara Y (1995) Apolipoprotein E genotype, Alzheimers pathologies and related gene expression in the aged population. Brain Res Mol Brain Res 29, 92-98.
19. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M (2007) Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 64, 862-871. (Pubitemid 46919842)
20. Baum L, Chen L, Ng HK, Pang CP (2000) Apolipoprotein E isoforms in Alzheimers disease pathology and etiology. Microsc Res Tech 50, 278-281. (Pubitemid 30651166)
21. Berlau DJ, Corrada MM, Head E, Kawas CH (2009) APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 72, 829-834.
22. Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ Sr., Soininen H (1998) Major decrease in the volume of the entorhinal cortex in patients with Alzheimers disease carrying the apolipoprotein E epsilon4 allele. J Neurol Neurosurg Psychiatry 65, 322-327. (Pubitemid 28408245)
23. Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr.,WeinerMW(2009) MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers. Brain 132, 1067-1077.
24. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2010) APOE epsilon2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord 30, 229-237.
25. Wolk DA, Dickerson BC (2010) Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentionalexecutive network function in Alzheimers disease. Proc Natl Acad Sci U S A 107, 10256-10261.
26. Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC (2004) Impact of APOE in mild cognitive impairment. Neurology 63, 1898-1901. (Pubitemid 39532387)
27. Geroldi C, Pihlajamaki M, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB (1999) APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53, 1825-1832. (Pubitemid 29530361)
28. Filippini N, Rao A,Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I,Williams J, Nichols T, Whitcher B, Matthews PM (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimers disease. Neuroimage 44, 724-728.
29. Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr.,WeinerMW, ThompsonPM(2008) Tensor-based morphometry as a neuroimaging biomarker for Alzheimers disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 43, 458-469.
30. Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR (2009) Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry 66, 81-87.
31. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimers disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334, 752-758. (Pubitemid 26089356)
32. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2005) Correlations between apolipoprotein E epsilon4 gene dose and brainimaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 102, 8299-8302. (Pubitemid 40800083)
33. Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM (2010) APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol 67, 93-98.
34. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC (1997) Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 48, 985-989.
35. Mueller SG, Schuff N, Raptentsetsang S, Elman J, Weiner MW(2008) Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimers disease using high resolution MRI at 4 T. Neuroimage 42, 42-48.
36. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH (2006) Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 67, 1221-1224. (Pubitemid 44563831)
37. Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, Bookheimer SY (2008) Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 41, 1177-1183.
38. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 6, 494-500. (Pubitemid 46734757)
39. Lemaitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alperovitch A, Mazoyer B (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24, 1205-1213. (Pubitemid 40164522)
40. Espeseth T,Westlye LT, Fjell AM,Walhovd KB, Rootwelt H, Reinvang I (2008) Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 29, 329-340. (Pubitemid 351215592)
41. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L (2006) Reduced hippocampal volume in nondemented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 396, 23-27. (Pubitemid 43233781)
42. Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2010) Effect of APOE epsilon4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis 21, 947-966.
43. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361, 255-263.
44. Jernigan TL, Archibald SL, Fennema-Notestine C, GamstAC, Stout JC, Bonner J, Hesselink JR (2001) Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 22, 581-594. (Pubitemid 32607743)
45. Thambisetty M, Wan J, Carass A, An Y, Prince JL, Resnick SM (2010) Longitudinal changes in cortical thickness associated with normal aging. Neuroimage 52, 1215-1223.
46. Kremen WS, Thompson-Brenner H, Leung YM, Grant MD, Franz CE, Eisen SA, Jacobson KC, Boake C, Lyons MJ (2006) Genes, environment, and time: the Vietnam Era Twin Study of Aging (VETSA). Twin Res Hum Genet 9, 1009-1022. (Pubitemid 46093794)
47. Goldberg J, Curran B, Vitek ME, Henderson WG, Boyko EJ (2002) The Vietnam Era Twin Registry. Twin Res 5, 476-481. (Pubitemid 35315506)
48. Centers for Disease Control and Prevention. Health data for all ages online.Available at: http://www.cdc.gov/nchs/hdi.htm. Accessed April 20, 2007
49. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373-379.
50. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548. (Pubitemid 20107994)
51. Rebeck GW, Perls TT,West HL, Sodhi P, Lipsitz LA, Hyman BT (1994) Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimers patients and cognitively normal individuals. Neurology 44, 1513-1516. (Pubitemid 24247449)
52. Lyons MJ,York TP, Franz CE, Grant MD, Eaves LJ, Jacobson KC, Schaie KW, Panizzon MS, Boake C, Xian H, Toomey R, Eisen SA, Kremen WS (2009) Genes determine stability and the environment determines change in cognitive ability during years of adulthood. Psychol Sci 20, 1146-1152.
53. Kremen WS, Prom-Wormley E, Panizzon MS, Eyler LT, Fischl B, Neale MC, Franz CE, Lyons MJ, Pacheco J, Perry ME, Stevens A, Schmitt JE, Grant MD, Seidman LJ, Thermenos HW, Tsuang MT, Eisen SA, Dale AM, Fennema-Notestine C (2010) Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. Neuroimage 49, 1213-1223.
54. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van derKouwe A, Killiany R,Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355. (Pubitemid 34162530)
55. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194. (Pubitemid 29369874)
56. Fischl B, Sereno MI, Dale AM (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195-207. (Pubitemid 29369875)
57. Fischl B,Van DerKouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex 14, 11-22. (Pubitemid 38018050)
58. Buckner RL, Head D, Parker J, Fotenos AF,Marcus D, Morris JC, Snyder AZ (2004) A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 23, 724-738. (Pubitemid 39370623)
59. Fennema-Notestine C, Gamst AC, Quinn BT, Pacheco J, Jernigan TL, Thal L, Buckner R, Killiany R, Blacker D, Dale AM, Fischl B, Dickerson B, Gollub RL (2007) Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data. Neuroinformatics 5, 235-245.
60. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968-980. (Pubitemid 44183792)
61. Barnes J, Ridgway GR, Bartlett J, Henley SM, Lehmann M, Hobbs N, Clarkson MJ, MacManus DG, Ourselin S, Fox NC (2010) Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 53, 1244-1255.
62. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B (2006) Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage
63. Stonnington CM, Tan G, Kloppel S, Chu C, Draganski B, Jack CRJr., Chen K, Ashburner J, Frackowiak RS (2008) Interpreting scan data acquired from multiple scanners: a study with Alzheimers disease. Neuroimage 39, 1180-1185.
64. Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, Weeber EJ, Turner RS, Xu B, Rebeck GW, Hoe HS (2009) ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 29, 15317-15322.
65. Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML (2009) Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimers disease and frontotemporal dementia. Proc Natl Acad Sci U S A 106, 2018-2022.
66. Cherbuin N, Leach LS, Christensen H, Anstey KJ (2007) Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 24, 348-362. (Pubitemid 350036691)
67. Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC,Welsh-BohmerKA(2009) Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Arch Neurol 66, 1378-1383.
68. Rao VS, Cupples A, van Duijn CM, Kurz A, Green RC, Chui H, Duara R, Auerbach SA, Volicer L, Wells J, van Broeckhoven C, Growdon JH, Haines JL, Farrer LA (1996) Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am J Hum Genet 59, 664-675. (Pubitemid 26269045)
69. Fleisher A, Grundman M, Jack CR Jr., Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ (2005) Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 62, 953-957. (Pubitemid 40973457)
70. Panizzon MS, Hauger R, Dale AM, Eaves LJ, Eyler LT, Fischl B, Fennema-Notestine C, Franz CE, Grant MD, Jak AJ, Jacobson KC, Lyons MJ, Mendoza SP, Neale MC, Prom-Wormley EC, Seidman LJ, Tsuang MT, Xian H, Kremen WS (2010) Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men. Neurology 75, 874-880.
71. Gerritsen L, Comijs HC, Deeg DJ, Penninx BW, Geerlings MI Salivary cortisol, APOE-varepsilon4 allele and cognitive decline in a prospective study of older persons. Neurobiol Aging (In Press)
72. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52, 1048-1060.
73. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK (2002) Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 5, 1242-1247. (Pubitemid 35247185)
74. Jernigan TL, Gamst AC (2005) Changes in volume with age-consistency and interpretation of observed effects. Neurobiol Aging 26, 1271-1274; discussion 1275-1278. (Pubitemid 41338542)